This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDWARD A. DAINKO, MD; HAROLD A. PAUL, MD; ANDRES GABEL, MD; EDWARD J. BEATTIE, MD

AMA Arch Surg. 1963;86(6):1050-1061.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There is no ideal way to collect total pancreatic secretion, uncontaminated, over an extended period of time. The ideal pancreatic fistula would be one through which the entire flow of pancreatic juice could be directed in its pure form with no alteration in the pancreas itself.

This study is concerned with the development of an improved method of collecting total pancreatic secretion and with evaluating the pancreatic secretion of certain antibacterial agents.

There have been no instances found in the available literature of the study of antibacterial agent secretion by the canine pancreas. The earliest recorded instance in the literature of human pancreatic secretion of an antibacterial agent was by Schnitker²⁴ in 1943. Schnitker noted that after administration of sulfonamides they were present in the pancreatic juice. In 1944, Miller and Wiper¹⁵ reported that sulfanilamide was found in approximately the same concentration in the pancreatic juice as in . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

From the Department of Surgery, Presbyterian-St. Luke's Hospital, affiliated with the University of Illinois School of Medicine.

Footnotes
Presented at the 70th Annual Session of the Western Surgical Association, St. Louis, Nov 29-Dec 1, 1962.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?